Longeveron Provides Corporate Update and Announces 2023 Strategic Priorities and Anticipated Milestones

January 6, 2023

https://www.globenewswire.com/news-release/2023/01/06/2584445/0/en/Longeveron-Provides-Corporate-Update-and-Announces-2023-Strategic-Priorities-and-Anticipated-Milestones.html

– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty in Japan in 1Q23 –

– Extended cash runway into 2H24 –

Read more at globenewswire.com

Related news for (LGVN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.